5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mesoporous Silica Nanoparticles for Targeting Subcellular Organelles

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Current chemotherapy treatments lack great selectivity towards tumoral cells, which leads to nonspecific drug distribution and subsequent side effects. In this regard, the use of nanoparticles able to encapsulate and release therapeutic agents has attracted growing attention. In this sense, mesoporous silica nanoparticles (MSNs) have been widely employed as drug carriers owing to their exquisite physico-chemical properties. Because MSNs present a surface full of silanol groups, they can be easily functionalized to endow the nanoparticles with many different functionalities, including the introduction of moieties with affinity for the cell membrane or relevant compartments within the cell, thus increasing the efficacy of the treatments. This review manuscript will provide the state-of-the-art on MSNs functionalized for targeting subcellular compartments, focusing on the cytoplasm, the mitochondria, and the nucleus.

          Related collections

          Most cited references101

          • Record: found
          • Abstract: not found
          • Article: not found

          Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Principles of nanoparticle design for overcoming biological barriers to drug delivery.

            Biological barriers to drug transport prevent successful accumulation of nanotherapeutics specifically at diseased sites, limiting efficacious responses in disease processes ranging from cancer to inflammation. Although substantial research efforts have aimed to incorporate multiple functionalities and moieties within the overall nanoparticle design, many of these strategies fail to adequately address these barriers. Obstacles, such as nonspecific distribution and inadequate accumulation of therapeutics, remain formidable challenges to drug developers. A reimagining of conventional nanoparticles is needed to successfully negotiate these impediments to drug delivery. Site-specific delivery of therapeutics will remain a distant reality unless nanocarrier design takes into account the majority, if not all, of the biological barriers that a particle encounters upon intravenous administration. By successively addressing each of these barriers, innovative design features can be rationally incorporated that will create a new generation of nanotherapeutics, realizing a paradigmatic shift in nanoparticle-based drug delivery.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mesoporous materials for drug delivery.

              Research on mesoporous materials for biomedical purposes has experienced an outstanding increase during recent years. Since 2001, when MCM-41 was first proposed as drug-delivery system, silica-based materials, such as SBA-15 or MCM-48, and some metal-organic frameworks have been discussed as drug carriers and controlled-release systems. Mesoporous materials are intended for both systemic-delivery systems and implantable local-delivery devices. The latter application provides very promising possibilities in the field of bone-tissue repair because of the excellent behavior of these materials as bioceramics. This Minireview deals with the advances in this field by the control of the textural parameters, surface functionalization, and the synthesis of sophisticated stimuli-response systems.
                Bookmark

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                18 December 2020
                December 2020
                : 21
                : 24
                : 9696
                Affiliations
                [1 ]Departamento de Química en Ciencias Farmacéuticas, Instituto de Investigación Sanitaria Hospital 12 de Octubre i + 12, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain; migisber@ 123456ucm.es (M.G.-G.); danlozan@ 123456ucm.es (D.L.)
                [2 ]Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28029 Madrid, Spain
                Author notes
                [* ]Correspondence: vallet@ 123456ucm.es ; Tel.: +34-91-394-1843
                [†]

                These authors contributed equally to this work.

                Author information
                https://orcid.org/0000-0001-9815-0354
                https://orcid.org/0000-0001-5902-9201
                https://orcid.org/0000-0002-6104-4889
                Article
                ijms-21-09696
                10.3390/ijms21249696
                7766291
                33353212
                806757e9-cf28-4a38-800a-b938a4739b97
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 05 December 2020
                : 16 December 2020
                Categories
                Review

                Molecular biology
                mesoporous silica nanoparticles,targeting,subcellular targeting,endosomal escape,mitochondria,nucleus,nanomedicine,stimuli-responsive,drug delivery

                Comments

                Comment on this article